Carterra®, now part of Revvity, is a leading provider of innovative, high-throughput (HT) Surface Plasmon Resonance (SPR) biosensor technology. Their flagship LSA® and LSA HyperDetect™ platforms are designed to dramatically accelerate the discovery and development of novel therapeutics. By enabling researchers to characterize hundreds of binding interactions in parallel with minimal sample consumption, Carterra's technology significantly reduces timelines for critical processes such as antibody screening, epitope binning, kinetics analysis, and quantitation. Adopted by major pharmaceutical companies, biotechs, and academic research institutions globally, Carterra empowers scientists to make faster, more informed decisions in the quest for new medicines.
Serves as the central hub for Carterra's operations, including research and development of its LSA and LSA HyperDetect platforms, instrument manufacturing, global commercial strategy, marketing, and administrative functions. It is the primary innovation and operational site for the Carterra brand under Revvity.
The facility houses specialized laboratories for optical biosensor research and development, clean rooms for instrument assembly, and application labs for customer demonstrations and support, alongside collaborative office spaces designed to foster innovation.
Carterra fosters a scientifically driven, innovative, and collaborative work environment. Employees are typically focused on cutting-edge technology development and addressing complex challenges in biopharmaceutical discovery, with a strong emphasis on teamwork, customer impact, and scientific excellence.
The Salt Lake City HQ is crucial for Carterra's specialized operations in high-throughput SPR technology, benefiting from Utah's growing life sciences corridor and serving as the global hub for the Carterra brand within Revvity.
While Carterra's primary operations and headquarters are in Salt Lake City, Utah, the company maintains a significant global presence to support its international customer base. This is achieved through a network of direct sales personnel, field application scientists, and service engineers strategically located across North America, Europe, and the Asia-Pacific region. This distributed team ensures localized support, expert training, and collaborative scientific partnerships, enabling researchers worldwide to effectively utilize Carterra's HT-SPR platforms for their drug discovery and development programs.
820 S. Main Street, Suite A4
Salt Lake City
UT
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Carterra' leadership includes:
Carterra has been backed by several prominent investors over the years, including:
In the past 12 months, there have been no high-profile public announcements regarding new hires or departures within Carterra's specific executive leadership team as listed on their official website. The team appears to have remained stable since its integration into Revvity. Significant leadership changes affecting Carterra, if any, would likely be part of broader Revvity corporate-level announcements.
Discover the tools Carterra uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Carterra likely utilizes common corporate email patterns. Based on industry standards and available information, the most probable formats include [first_initial][last_name]@carterra-bio.com (e.g., jdoe@carterra-bio.com) and potentially [first_name].[last_name]@carterra-bio.com (e.g., jane.doe@carterra-bio.com).
[first_initial][last]@carterra-bio.com
Format
jdoe@carterra-bio.com
Example
75%
Success rate
Business Wire • October 24, 2023
Carterra announced the commercial launch of its LSA HyperDetect platform, significantly enhancing the sensitivity of its High-Throughput Surface Plasmon Resonance (HT-SPR) technology. This innovation is designed to enable researchers to analyze challenging drug targets like GPCRs and ion channels with greater precision and throughput....more
Business Wire • June 13, 2023
Carterra highlighted the crucial contribution of its LSA platform in the discovery of a novel, first-in-class checkpoint inhibitor by Numab Therapeutics. The candidate, developed with insights from Carterra's HT-SPR technology, has successfully advanced into clinical trials, showcasing the LSA's impact on accelerating therapeutic antibody discovery....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Carterra, are just a search away.